Kala Pharmaceuticals, Inc. Made Headway
Fri, Mar 11, 2022 at 05:30 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) shot up at $1.69, a gain of 33.1%. On Thu, Mar 10, 2022, KALA:NASDAQ hit a New 2-Week High of $1.27. The stock got featured on our News Catalysts scanner on Fri, Feb 18, 2022 at 06:36 PM in the 'PRIVATE PLACEMENT' category. From Thu, Feb 24, 2022, the stock recorded 20.00% Up Days and 45.45% Green Days
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- The Marygold Companies Inc. (MGLD:NYSEMKT), 89.4%
- TeraWulf Inc. (WULF:NASDAQ), 49.29%
- Guardforce AI Co. Limited (GFAI:NASDAQ), 45.04%
- Clearside Biomedical, Inc. (CLSD:NASDAQ), 42.59%
- Excellon Resources Inc. (EXN:NYSEMKT), 40.82%
- Solid Biosciences Inc. (SLDB:NASDAQ), 37.38%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 36.7%
- 4D pharma plc (LBPS:NASDAQ), 35.25%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 33.07%
- Mullen Automotive Inc. (MULN:NASDAQ), 26.17%